Today: 23 April 2026
Subscribe
Browse Category

Stock Market 9 December 2025

Rheinmetall AG Stock on December 9, 2025: German Mega‑Orders, Record Backlog and What Analysts Expect Next

Rheinmetall AG Stock on December 9, 2025: German Mega‑Orders, Record Backlog and What Analysts Expect Next

Rheinmetall shares rose up to 4% on December 9 as Germany’s Bundestag prepared to approve €52 billion in new defense procurement, including major contracts for Puma vehicles and ammunition. The stock traded near €1,645, up 10% over five sessions and 160% year-to-date. Analysts estimate the Puma deal alone could bring Rheinmetall €2 billion. A separate tank ammunition order worth several hundred million euros was announced December 8.
9 December 2025
··
Federal National Mortgage Association (Fannie Mae) Stock in December 2025: Michael Burry’s Big Bet, Trump’s IPO Plans and What Comes Next

Federal National Mortgage Association (Fannie Mae) Stock in December 2025: Michael Burry’s Big Bet, Trump’s IPO Plans and What Comes Next

Fannie Mae’s stock closed at $11.44 on December 8, up 8% over five days and nearly 250% year-to-date, according to MarketScreener. Shares jumped after investor Michael Burry disclosed sizable stakes in both Fannie Mae and Freddie Mac and predicted IPOs for the mortgage giants. Fannie’s 52-week range spans $2.24 to $15.98, highlighting recent volatility.
9 December 2025
····
Astera Labs (ALAB) Stock Jumps on AI Optimism: Latest News, Analyst Price Targets and Forecasts for December 9, 2025

Astera Labs (ALAB) Stock Jumps on AI Optimism: Latest News, Analyst Price Targets and Forecasts for December 9, 2025

Astera Labs shares jumped 9% to $175.74 in late-morning trading Tuesday after new analyst commentary and institutional filings. Bank of Nova Scotia halved its stake in the company, according to fresh 13F disclosures, following heavy insider selling in recent months. The stock’s market cap stands near $27–28 billion, with institutional ownership above 70% and short interest around 5–6%.
9 December 2025
·
Toll Brothers Stock Slides After Q4 2025 Earnings Miss and Cautious 2026 Outlook: What It Means for TOL Investors

Toll Brothers Stock Slides After Q4 2025 Earnings Miss and Cautious 2026 Outlook: What It Means for TOL Investors

Toll Brothers shares fell about 2% to $136 Tuesday after fiscal Q4 results showed revenue at $3.41 billion and EPS of $4.58, missing consensus. Margins narrowed, with home sales gross margin at 25.5% versus 26% a year ago. Cash from operations dropped 46% to $370 million. The company’s 2026 outlook calls for lower home deliveries.
9 December 2025
··
NextEra Energy (NEE) Stock on December 9, 2025: Google Cloud AI Grid Deal, Price Action and Analyst Forecasts

NextEra Energy (NEE) Stock on December 9, 2025: Google Cloud AI Grid Deal, Price Action and Analyst Forecasts

NextEra Energy shares traded near $80.55 by late morning December 9, steady after a 3% drop on heavy volume the previous session. The company announced new deals with Google Cloud, Meta, and Exxon, and raised long-term earnings guidance at its New York investor day. NextEra reported Q3 adjusted EPS of $1.13, beating estimates, and declared a $0.5665 quarterly dividend. The utility operates about 76 GW of capacity across North America.
9 December 2025
···
Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Paramount Skydance launched a $30 per share all-cash hostile bid for Warner Bros. Discovery, valuing the company at $108.4 billion including debt and challenging Netflix’s $72 billion agreement for WBD’s studios and streaming. WBD shares traded around $27.23 Tuesday, up over 4%, with year-to-date gains near 147%. The stock price sits just below Paramount’s offer and roughly matches the Netflix deal’s implied value.
9 December 2025
····
Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

Cemtrex shares surged 130% Monday to close at $7.05 after wild trading, then dropped about 14% in Tuesday pre-market. The move follows a series of reverse stock splits and a November deal to acquire aerospace firm Invocon for $7.06 million. Cemtrex’s market value remains near $5 million, with a 52-week range of $2.50 to $57.75.
9 December 2025
··
Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Sezzle Inc. will join the S&P SmallCap 600 index on December 15, replacing Vital Energy, S&P Dow Jones Indices said December 8. Sezzle shares closed at $67.70, up 6–8% in after-hours trading after the announcement. The company posted Q3 net income of $26.7 million on $116.8 million revenue, both up sharply year over year. Sezzle’s market cap stands at about $2.3 billion.
9 December 2025
··
‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

A/H3N2 subclade K, known as the “K-strain,” now makes up about 90% of flu samples in the UK and Japan and has been found on every continent. NHS leaders in London report hospital flu admissions have tripled from last year, with no sign of a peak. Early data indicate this season’s flu vaccine remains strongly protective against severe illness.
9 December 2025
UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

The FTSE 100 closed nearly flat at 9,650 on December 9, 2025, as traders awaited a US Federal Reserve decision. Trading volumes were heavy in Lloyds, Legal & General, Glencore, Vodafone, Barclays, Tesco, BP, BT, Rolls-Royce, Magnum Ice Cream, and British American Tobacco. Unilever’s ice-cream spin-off and strong bank shares featured among the session’s main themes.
9 December 2025
··
UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

The FTSE 100 closed down 0.1% at about 9,640 on Tuesday, its lowest in two weeks, as investors awaited central bank decisions. British American Tobacco fell 3.5–4.5% after warning of slower growth in heated-tobacco and vaping. UK consumer data showed November card spending down 1.1% year-on-year, the steepest drop since early 2021. Retail sales growth remained weak despite Black Friday.
9 December 2025
···········
UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

Unilever shares jumped 13.1% in London after the company completed the spin-off of its ice cream business and a share consolidation. The FTSE 100 closed up 0.08% at 9,653.19, while the FTSE 250 rose 0.17%. WPP, Babcock, Trustpilot, Ocado, Helios Towers, Man Group, and Moonpig also posted strong gains. European markets edged higher as investors awaited the US Federal Reserve meeting.
9 December 2025
·
Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Structure Therapeutics shares closed at $69.98 on December 9, 2025, up 102% after positive Phase 2b trial results for its oral obesity drug aleniglipron. The stock hit a new 52-week high of $94.90 intraday, pushing market value to $4.25 billion. The company announced a $500 million equity offering following the surge. Aleniglipron showed up to 15.3% placebo-adjusted weight loss in studies.
9 December 2025
··
AMD Stock on December 9, 2025: AI Supercomputers, OpenAI Deal and Wall Street Targets in Focus

AMD Stock on December 9, 2025: AI Supercomputers, OpenAI Deal and Wall Street Targets in Focus

AMD shares traded near $221 on Tuesday, up 190% from their 52-week low but 17% below their high. Q3 2025 revenue reached $9.25 billion, beating estimates, with data center sales up 22% and PC chip revenue up 46% year over year. The company guided Q4 revenue to about $9.6 billion. AMD’s market cap stands in the mid-$300 billion range.
9 December 2025
···
Procter & Gamble (PG) Stock Hits Two‑Year Low as CFO Sounds Alarm on U.S. Consumer – What It Means for Investors Now

Procter & Gamble (PG) Stock Hits Two‑Year Low as CFO Sounds Alarm on U.S. Consumer – What It Means for Investors Now

Procter & Gamble shares fell to about $138 on December 9, 2025, down 23% from their 52-week high and near a two-year low after an analyst downgrade and cautious outlook from management. CFO Andre Schulten warned of a “more volatile” U.S. consumer environment, with significant declines in category volume and value in October and November.
9 December 2025
·
Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know

Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know

Exicure shares surged over 100% in pre-market trading December 9 after reporting positive topline Phase 2 results for burixafor in multiple myeloma at the ASH meeting. The trial met its primary endpoint in 17 of 19 patients, with no serious drug-related adverse events. XCUR closed at $5.33 on December 8, up 8.78%, and traded as high as $10.84 pre-market, pushing market cap to around $30–40 million.
9 December 2025
··
Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

Wave Life Sciences shares jumped about 147% Monday after positive data on its experimental RNA obesity drug, leading US stock gainers. The Dow fell 0.45%, S&P 500 lost 0.35%, and Nasdaq slipped 0.14% as investors awaited Wednesday’s Federal Reserve decision. Nvidia rose after the US allowed exports of its H200 AI chips to China with a 25% fee.
9 December 2025
····
Most Active Stocks Today (December 9, 2025): Nvidia, Tesla, Wave Life Sciences and Confluent Lead a Fed-Focused Wall Street

Most Active Stocks Today (December 9, 2025): Nvidia, Tesla, Wave Life Sciences and Confluent Lead a Fed-Focused Wall Street

Nvidia and AI chip stocks led US trading volumes Monday after the Biden administration cleared Nvidia’s H200 chips for export to China, with the government taking a 25% revenue cut. The S&P 500, Dow, and Nasdaq all closed just below record highs. Investors await the Fed’s final 2025 policy decision, with markets expecting a third rate cut this year. Treasury yields and the dollar held steady.
9 December 2025
····
1 … 1,033 1,034 1,035 1,036 1,037 … 1,384

Stock Market Today

  • Jim Cramer's Top 10 Market Watch Points for April 23
    April 23, 2026, 9:22 AM EDT. Stock futures declined modestly after S&P 500 and Nasdaq hit records on Iran ceasefire news. Texas Instruments' shares surged over 10% premarket on strong earnings and bullish upgrades from Barclays and Bank of America. Honeywell fell 5%, but investors await its aerospace spin-off on June 29. ServiceNow slumped nearly 14% despite CEO optimism, with lowered price targets citing concerns over growth and AI costs. IBM shares dropped 7% on slowing revenue growth and AI-related client worries. Tesla beat Q1 earnings estimates; however, capex guidance rose, adding free cash flow pressure. Tesla's humanoid robot and Intel's new chip process partnership are market highlights, with Intel shares up 2%. Lam Research reported strong revenue and guidance but shares held steady after 55% 2026 gains.

Latest article

Amazon Stock (AMZN) Gains After $25 Billion Anthropic Deal, With AWS Earnings Now the Key Test

Amazon Stock (AMZN) Gains After $25 Billion Anthropic Deal, With AWS Earnings Now the Key Test

23 April 2026
Amazon shares rose 2.18% to $255.36 after the company expanded its partnership with Anthropic, which committed to spend over $100 billion on AWS over 10 years. Amazon will invest $5 billion in Anthropic now, with a possible $20 billion more tied to milestones. The deal comes ahead of Amazon’s first-quarter earnings on April 29. Analysts raised price targets, citing stronger AWS prospects.
Nvidia Stock Today: NVDA Rises as Google Unveils New AI Chips, Still Backs Vera Rubin

Nvidia Stock Today: NVDA Rises as Google Unveils New AI Chips, Still Backs Vera Rubin

23 April 2026
Nvidia shares rose 1.3% to $202.50 premarket after Google launched new TPU 8 AI chips and announced it will offer Nvidia’s Vera Rubin NVL72 server platform. Alphabet kept its 2026 spending plan at $175 billion to $185 billion. SK Hynix reported AI memory demand outstripping supply. Broadcom signed a deal to supply Google’s custom AI chips through 2031.
Microsoft Stock Falls Ahead of Earnings as $18 Billion Australia AI Bet Runs Into Fresh Wall Street Doubts

Microsoft Stock Falls Ahead of Earnings as $18 Billion Australia AI Bet Runs Into Fresh Wall Street Doubts

23 April 2026
Microsoft shares fell about 2% in premarket trading Thursday after announcing a A$25 billion ($17.9 billion) AI investment in Australia, its largest ever in the country. The drop followed sector-wide declines sparked by IBM and ServiceNow growth concerns. Microsoft’s plan includes Azure AI infrastructure, cybersecurity, and training three million Australians by 2028. Investors await April 29 earnings for signs AI spending is boosting cloud growth.
Go toTop